title: [Permanent cardiac pacing in vasovagal syncope and carotid sinus syndrome].
abstract: Vasovagal syncope and carotid sinus syndrome are common conditions in young and elderly people, respectively, mostly with benign prognosis. Nevertheless, severe or "malignant" syncopal attacks in some patients may be associated with life-threatening injury. Unfortunately, up to now almost all drug trials have failed to demonstrate any benefit in preventing syncope and interventional approach (pacemaker) may be appropriate. This article contains literature review and discussion of indications for pacing in vasovagal syncope and carotid sinus syndrome.
authors.forename: D V
authors.initials: DV
authors.lastname: Dupliakov
authors.forename: G A
authors.initials: GA
authors.lastname: Golovina
authors.forename: M E
authors.initials: ME
authors.lastname: Zemlianova
authors.forename: S M
authors.initials: SM
authors.lastname: Khokhlunov
authors.forename: V P
authors.initials: VP
authors.lastname: Poliakov
mesh_terms: D017704:Baroreflex / Q000187:drug effects; D002304:Cardiac Pacing, Artificial / Q000379:methods / Q000592:standards; D002317:Cardiovascular Agents / Q000627:therapeutic use; D002346:Carotid Sinus / Q000187:drug effects / Q000473:pathology / Q000503:physiopathology; D006801:Humans; D010138:Pacemaker, Artificial / Q000592:standards*; D018579:Patient Selection; D011311:Pressoreceptors / Q000473:pathology / Q000503:physiopathology; D016032:Randomized Controlled Trials as Topic; D012008:Recurrence; D019462:Syncope, Vasovagal / Q000209:etiology / Q000473:pathology / Q000503:physiopathology / Q000628:therapy; D017211:Treatment Failure
chemical_list: D002317:Cardiovascular Agents